WOLFGANG WINKELMAYER to Humans
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Humans.
Connection Strength
3.357
-
Prospectively Examining Outcomes After Living Kidney Donation: Informing the Altruist. JAMA. 2024 07 23; 332(4):285-286.
Score: 0.026
-
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 07; 106(1):145-153.
Score: 0.025
-
Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 01 17; 329(3):205-206.
Score: 0.023
-
[Nomenclature for kidney function and kidney diseases - Improving assessment and prognosis through precision and comprehensibility]. Dtsch Med Wochenschr. 2022 10; 147(21):1398-1406.
Score: 0.023
-
The landscape of renal replacement therapy in Veterans Affairs Medical Center intensive care units. Ren Fail. 2021 Dec; 43(1):1146-1154.
Score: 0.021
-
The Association of Pre-Kidney Transplant Dialysis Modality with de novo Posttransplant Heart Failure. Cardiorenal Med. 2021; 11(5-6):209-217.
Score: 0.021
-
Cardiovascular Safety of Roxadustat in CKD Anemia: A Fig Leaf Named Noninferiority. Clin J Am Soc Nephrol. 2021 08; 16(8):1155-1157.
Score: 0.021
-
Black Race Coefficient in GFR Estimation and Prevalence of CKD-Related Complications. Clin J Am Soc Nephrol. 2021 10; 16(10):1562-1564.
Score: 0.021
-
Black Race Coefficient in GFR Estimation and Diabetes Medications in CKD: National Estimates. J Am Soc Nephrol. 2021 06 01; 32(6):1319-1321.
Score: 0.020
-
Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018. PLoS One. 2020; 15(12):e0243431.
Score: 0.020
-
A Global Accounting of Kidney Replacement Therapy. Am J Kidney Dis. 2021 03; 77(3):309-311.
Score: 0.020
-
Nephrology and COVID-19. JAMA. 2020 09 22; 324(12):1137-1138.
Score: 0.020
-
Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020 09; 29(5):489-496.
Score: 0.020
-
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. J Ren Care. 2020 Sep; 46(3):136.
Score: 0.020
-
Nomenclature for kidney function and disease: executive summary from a KDIGO consensus conference. Nat Rev Nephrol. 2020 08; 16(8):427-428.
Score: 0.019
-
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health. Clin J Am Soc Nephrol. 2020 07 01; 15(7):937-948.
Score: 0.019
-
Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. J Am Soc Nephrol. 2020 06; 31(6):1325-1334.
Score: 0.019
-
The dialysis care-policy issue: Guest Editors' introductory remarks. Semin Dial. 2020 01; 33(1):4.
Score: 0.019
-
Trends in the Medical Complexity and Outcomes of Medicare-insured Patients Undergoing Kidney Transplant in the Years 1998-2014. Transplantation. 2019 11; 103(11):2413-2422.
Score: 0.018
-
Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):351-360.
Score: 0.018
-
Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis. Clin J Am Soc Nephrol. 2019 07 05; 14(7):1029-1038.
Score: 0.018
-
Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. Eur Heart J. 2019 03 14; 40(11):887-898.
Score: 0.018
-
Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208.
Score: 0.017
-
Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis. 2019 03; 73(3):324-331.
Score: 0.017
-
Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
Score: 0.017
-
Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
Score: 0.017
-
Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation. Semin Nephrol. 2018 11; 38(6):618-628.
Score: 0.017
-
Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541.
Score: 0.017
-
Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 2018 09 01; 33(9):1590-1597.
Score: 0.017
-
Heterogeneity in Outcomes Among ?-Blockers Elucidated by Intradialytic Data. Am J Kidney Dis. 2018 09; 72(3):318-321.
Score: 0.017
-
Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Atrial Fibrillation. Clin J Am Soc Nephrol. 2018 09 07; 13(9):1423-1425.
Score: 0.017
-
The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
Score: 0.017
-
De Novo Heart Failure After Kidney Transplantation: Trends in Incidence and Outcomes. Am J Kidney Dis. 2018 08; 72(2):223-233.
Score: 0.017
-
Market Competition and Health Outcomes in Hemodialysis. Health Serv Res. 2018 10; 53(5):3680-3703.
Score: 0.016
-
Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
Score: 0.016
-
Treating Depression in Patients With Advanced CKD: Beyond the Generalizability Frontier. JAMA. 2017 11 21; 318(19):1873-1874.
Score: 0.016
-
Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States. Transplantation. 2017 10; 101(10):2636-2647.
Score: 0.016
-
A Case for More Frequent, Not Just Earlier, Nephrology Care of Patients Approaching ESRD? Am J Kidney Dis. 2017 08; 70(2):155-157.
Score: 0.016
-
Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study. BMC Nephrol. 2017 Jun 17; 18(1):196.
Score: 0.016
-
Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus. J Am Heart Assoc. 2017 Jun 07; 6(6).
Score: 0.016
-
Worldwide Preparedness for Kidney Health Care. JAMA. 2017 05 09; 317(18):1838-1839.
Score: 0.016
-
Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis. Nephrol Dial Transplant. 2017 May 01; 32(5):862-869.
Score: 0.016
-
Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145.
Score: 0.016
-
Nephrologists' Perspectives on Defining and Applying Patient-Centered Outcomes in Hemodialysis. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):454-466.
Score: 0.015
-
Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. Am J Kidney Dis. 2017 Jun; 69(6):771-779.
Score: 0.015
-
Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients. Am J Kidney Dis. 2017 May; 69(5):595-601.
Score: 0.015
-
Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. J Nephrol. 2017 Apr; 30(2):281-288.
Score: 0.015
-
Kidney Transplantation Outcomes across GN Subtypes in the United States. J Am Soc Nephrol. 2017 02; 28(2):632-644.
Score: 0.015
-
Predicting mortality over different time horizons: which data elements are needed? J Am Med Inform Assoc. 2017 01; 24(1):176-181.
Score: 0.015
-
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016 08; 90(2):411-421.
Score: 0.015
-
Early to Dialyze: Healthy and Wise? JAMA. 2016 May 24-31; 315(20):2171-2.
Score: 0.014
-
Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis. J Am Coll Cardiol. 2016 Mar 29; 67(12):1459-1469.
Score: 0.014
-
Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data. BMC Nephrol. 2016 Feb 09; 17:16.
Score: 0.014
-
Differences in Initial Hemodialysis Vascular Access Use Among Glomerulonephritis Subtypes in the United States. Am J Kidney Dis. 2016 Apr; 67(4):638-47.
Score: 0.014
-
Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease. BMC Nephrol. 2015 Dec 09; 16:204.
Score: 0.014
-
Coffee and caffeine consumption and the risk of hypertension in postmenopausal women. Am J Clin Nutr. 2016 Jan; 103(1):210-7.
Score: 0.014
-
Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA. Nephrol Dial Transplant. 2016 Feb; 31(2):290-8.
Score: 0.014
-
The Dawning of a New Day in CKD Anemia Care? J Am Soc Nephrol. 2016 Apr; 27(4):968-70.
Score: 0.014
-
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. Nephrol Dial Transplant. 2015 Dec; 30(12):2068-75.
Score: 0.014
-
Classifying individuals based on a densely captured sequence of vital signs: An example using repeated blood pressure measurements during hemodialysis treatment. J Biomed Inform. 2015 Oct; 57:219-24.
Score: 0.014
-
Treated and Untreated Kidney Failure: Quantifying an Outcome. Am J Kidney Dis. 2015 Aug; 66(2):187-9.
Score: 0.014
-
Timing of Dialysis Initiation-Do Health Care Setting or Provider Incentives Matter? Clin J Am Soc Nephrol. 2015 Aug 07; 10(8):1321-3.
Score: 0.014
-
Treatment of Hyperkalemia: From "Hyper K+" Strikeout to Home Run? JAMA. 2015 Jul 14; 314(2):129-30.
Score: 0.014
-
Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant. 2015 Oct; 30(10):1734-40.
Score: 0.014
-
Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. Am J Kidney Dis. 2015 Oct; 66(4):677-88.
Score: 0.014
-
Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
Score: 0.014
-
Comparative health services research across populations: the unused opportunities in big data. Kidney Int. 2015 Jun; 87(6):1094-6.
Score: 0.014
-
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. Am J Kidney Dis. 2015 Jul; 66(1):106-13.
Score: 0.013
-
Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis. Am J Kidney Dis. 2015 Jul; 66(1):69-74.
Score: 0.013
-
Comparison of longer-term outcomes after kidney transplantation between Hispanic and non-Hispanic whites in the United States. Am J Transplant. 2015 Feb; 15(2):499-507.
Score: 0.013
-
Perspectives on pregnancy in women with chronic kidney disease: systematic review of qualitative studies. Nephrol Dial Transplant. 2015 Apr; 30(4):652-61.
Score: 0.013
-
Use of novel oral anticoagulants in patients with end-stage renal disease. Hemodial Int. 2015 Jan; 19(1):150-3.
Score: 0.013
-
Prevention of acute kidney injury using vasoactive or antiplatelet treatment: three strikes and out? JAMA. 2014 Dec 03; 312(21):2221-2.
Score: 0.013
-
Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation. Nephrol Dial Transplant. 2015 Feb; 30(2):321-9.
Score: 0.013
-
Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.
Score: 0.013
-
Heparin use in hemodialysis patients following gastrointestinal bleeding. Am J Nephrol. 2014; 40(4):300-7.
Score: 0.013
-
Review: In CKD, novel oral anticoagulants do not differ from vitamin K antagonists for efficacy or bleeding. Ann Intern Med. 2014 Sep 16; 161(6):JC10.
Score: 0.013
-
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med. 2014 May; 174(5):699-707.
Score: 0.013
-
Commentary on 'the DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients': the calm before the 2016 storm? Am J Kidney Dis. 2014 May; 63(5):854-8.
Score: 0.013
-
State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol. 2014 Jun; 25(6):1321-9.
Score: 0.012
-
Cardiovascular disease: Still unresolved: warfarin in ESRD with atrial fibrillation. Nat Rev Nephrol. 2014 May; 10(5):244-5.
Score: 0.012
-
Warfarin treatment in patients with atrial fibrillation and advanced chronic kidney disease: sins of omission or commission? JAMA. 2014 Mar 05; 311(9):913-5.
Score: 0.012
-
Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014 Apr; 14(4):943-951.
Score: 0.012
-
Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25.
Score: 0.012
-
IV iron dosing regimens: choice of agent and dosing frequency. Nephrol News Issues. 2014 Feb; 28(2):10-1, 18.
Score: 0.012
-
Thematic synthesis of qualitative studies on patient and caregiver perspectives on end-of-life care in CKD. Am J Kidney Dis. 2014 Jun; 63(6):913-27.
Score: 0.012
-
Commentary on 'The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle': iron(y) abounds 2 years later. Am J Kidney Dis. 2013 Dec; 62(6):1217-20.
Score: 0.012
-
Predicting the outcomes of rhabdomyolysis: a good starting point. JAMA Intern Med. 2013 Oct 28; 173(19):1828-9.
Score: 0.012
-
Kidney disease and cardiovascular risk: whether black or white race matters. JAMA. 2013 Aug 21; 310(7):697-8.
Score: 0.012
-
Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. Am J Transplant. 2013 Jun; 13(6):1566-75.
Score: 0.012
-
Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. Clin J Am Soc Nephrol. 2013 Aug; 8(8):1336-42.
Score: 0.012
-
Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System. Am J Kidney Dis. 2013 Aug; 62(2):312-21.
Score: 0.012
-
Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrol. 2013 Apr 26; 14:97.
Score: 0.012
-
Use and safety of heparin-free maintenance hemodialysis in the USA. Nephrol Dial Transplant. 2013 Jun; 28(6):1589-602.
Score: 0.012
-
Assessments of causal effects--theoretically sound, practically unattainable, and clinically not so relevant. Clin J Am Soc Nephrol. 2013 Apr; 8(4):520-2.
Score: 0.012
-
More evidence on an abominable pairing: atrial fibrillation and kidney disease. Circulation. 2013 Feb 05; 127(5):560-2.
Score: 0.012
-
Commentary on 'The DOPPS Practice Monitor for US dialysis care: trends through December 2011': results from year one. Am J Kidney Dis. 2013 Feb; 61(2):346-8.
Score: 0.012
-
Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg. 2013 Jan; 95(1):20-8.
Score: 0.011
-
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol. 2012 Dec; 23(12):2042-9.
Score: 0.011
-
Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks? Curr Opin Nephrol Hypertens. 2012 Nov; 21(6):600-6.
Score: 0.011
-
Predialyis nephrology care of older individuals approaching end-stage renal disease. Semin Dial. 2012 Nov-Dec; 25(6):628-32.
Score: 0.011
-
Saving the kidneys by sparing intravenous chloride? JAMA. 2012 Oct 17; 308(15):1583-5.
Score: 0.011
-
Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013 Mar-Apr; 33(2):155-66.
Score: 0.011
-
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012 Nov 06; 126(19):2293-301.
Score: 0.011
-
Causal or casual?-The association between consumption of artificially sweetened carbonated beverages and vascular disease. J Gen Intern Med. 2012 Sep; 27(9):1100-1.
Score: 0.011
-
Treated and untreated kidney failure in older adults: what's the right balance? JAMA. 2012 Jun 20; 307(23):2545-6.
Score: 0.011
-
Comparative effectiveness research: what is it and why do we need it in nephrology? Nephrol Dial Transplant. 2012 Jun; 27(6):2156-61.
Score: 0.011
-
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis. 2012 Sep; 60(3):473-86.
Score: 0.011
-
Commentary on 'The DOPPS practice monitor for US dialysis care: trends through August 2011': an ESA confluence. Am J Kidney Dis. 2012 Jul; 60(1):165-7.
Score: 0.011
-
Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 2012 May-Jun; 25(3):341-53.
Score: 0.011
-
Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol. 2012 Jun; 23(6):1078-85.
Score: 0.011
-
Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005). J Nephrol. 2013 Mar-Apr; 26(2):281-8.
Score: 0.011
-
Use of secondary prevention medications among adults with reduced kidney function. Clin J Am Soc Nephrol. 2012 Apr; 7(4):604-11.
Score: 0.011
-
Commentary on 'The DOPPS practice monitor for US dialysis care: trends through April 2011': no surprises yet. Am J Kidney Dis. 2012 Feb; 59(2):312-4.
Score: 0.011
-
Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol. 2012 Mar; 23(3):495-506.
Score: 0.011
-
Altitude and the risk of cardiovascular events in incident US dialysis patients. Nephrol Dial Transplant. 2012 Jun; 27(6):2411-7.
Score: 0.011
-
What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gun. Circulation. 2011 Dec 20; 124(25):2805-8.
Score: 0.011
-
Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. Clin J Am Soc Nephrol. 2012 Feb; 7(2):289-96.
Score: 0.011
-
Air pollution and coronary risk in kidney transplant recipients. Am J Kidney Dis. 2011 Oct; 58(4):506-7.
Score: 0.011
-
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2662-8.
Score: 0.011
-
Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011 Aug 08; 171(15):1371-8.
Score: 0.010
-
Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J. 2011 Aug; 162(2):324-30.
Score: 0.010
-
Posttransplantation anemia: mechanisms and management. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1794-801.
Score: 0.010
-
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011 Sep; 58(3):409-17.
Score: 0.010
-
The effect of altitude change on anemia treatment response in hemodialysis patients. Am J Epidemiol. 2011 Apr 01; 173(7):768-77.
Score: 0.010
-
The 2011 ESRD prospective payment system: an uncontrolled experiment. Am J Kidney Dis. 2011 Apr; 57(4):542-6.
Score: 0.010
-
Tackling the Achilles' heel of hemodialysis. N Engl J Med. 2011 Jan 27; 364(4):372-4.
Score: 0.010
-
The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011 Feb; 22(2):349-57.
Score: 0.010
-
Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol. 2011 Apr; 6(4):864-9.
Score: 0.010
-
Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease care. Blood Purif. 2011; 31(1-3):66-9.
Score: 0.010
-
Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting. J Am Soc Nephrol. 2011 Jan; 22(1):1-2.
Score: 0.010
-
The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5.
Score: 0.010
-
Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):57-65.
Score: 0.010
-
Off-label use of phosphate binders in non-dialysis-dependent CKD. Am J Kidney Dis. 2010 Nov; 56(5):813-6.
Score: 0.010
-
Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients. Clin J Am Soc Nephrol. 2011 Jan; 6(1):175-83.
Score: 0.010
-
Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure. Clin Pharmacol Ther. 2010 Oct; 88(4):548-54.
Score: 0.010
-
On the relative safety of intravenous iron formulations: new answers, new questions. Am J Hematol. 2010 Sep; 85(9):643-4.
Score: 0.010
-
Kidney disease and antihypertensive medication adherence: the need for improved measurement tools. Am J Kidney Dis. 2010 Sep; 56(3):423-6.
Score: 0.010
-
Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis. Semin Dial. 2010 Sep-Oct; 23(5):486-91.
Score: 0.010
-
Medication issues in older individuals with CKD. Adv Chronic Kidney Dis. 2010 Jul; 17(4):320-8.
Score: 0.010
-
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010 Mar 03; 303(9):857-64.
Score: 0.009
-
ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized? Drugs Aging. 2010 Feb 01; 27(2):87-94.
Score: 0.009
-
Impact of reimbursement changes on statin use among patients with diabetes in Austria. Wien Klin Wochenschr. 2010 Feb; 122(3-4):89-94.
Score: 0.009
-
Chronic on acute renal failure: long-term implications of severe acute kidney injury. JAMA. 2009 Sep 16; 302(11):1227-9.
Score: 0.009
-
Lessons from geographic variations in predialysis nephrology care. J Am Soc Nephrol. 2009 May; 20(5):930-2.
Score: 0.009
-
Altitude and all-cause mortality in incident dialysis patients. JAMA. 2009 Feb 04; 301(5):508-12.
Score: 0.009
-
Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury. Am J Med. 2008 Dec; 121(12):1092-8.
Score: 0.009
-
Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy. Arch Intern Med. 2008 Nov 24; 168(21):2368-75.
Score: 0.009
-
Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1415-22.
Score: 0.008
-
The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol. 2008 Jul; 19(7):1389-95.
Score: 0.008
-
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
Score: 0.008
-
Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age. Am J Cardiol. 2008 Jun 01; 101(11):1531-6.
Score: 0.008
-
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice. Am J Kidney Dis. 2008 Mar; 51(3):362-5.
Score: 0.008
-
Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol. 2008 Mar; 3 Suppl 2:S49-55.
Score: 0.008
-
Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med. 2008 Feb; 23(2):216-8.
Score: 0.008
-
Use of recommended medications after myocardial infarction in Austria. Eur J Epidemiol. 2008; 23(2):153-62.
Score: 0.008
-
Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors. Int J Cardiol. 2008 Apr 10; 125(2):172-7.
Score: 0.008
-
Cardiovascular risk and the thiazolidinediones: d?j? vu all over again? JAMA. 2007 Sep 12; 298(10):1216-8.
Score: 0.008
-
Benzodiazepine use and mortality of incident dialysis patients in the United States. Kidney Int. 2007 Dec; 72(11):1388-93.
Score: 0.008
-
Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 01; 100(7):1061-7.
Score: 0.008
-
Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Health Aff (Millwood). 2007 May-Jun; 26(3):800-7.
Score: 0.008
-
Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant. 2007 Apr; 7(4):872-9.
Score: 0.008
-
A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007 Jun; 20(6):505-11.
Score: 0.008
-
Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease. Kidney Int. 2007 May; 71(9):938-45.
Score: 0.008
-
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007 Aug; 93(8):945-51.
Score: 0.008
-
Angiotensin inhibition after myocardial infarction: does drug class matter? J Gen Intern Med. 2006 Dec; 21(12):1242-7.
Score: 0.008
-
Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007 Jan; 71(2):153-8.
Score: 0.008
-
A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006 Dec; 21(12):3559-66.
Score: 0.007
-
Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes. Diabetes Care. 2006 Oct; 29(10):2210-7.
Score: 0.007
-
Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol. 2006 Jul; 1(4):796-801.
Score: 0.007
-
Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making. 2006 May-Jun; 26(3):247-54.
Score: 0.007
-
Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure. Clin J Am Soc Nephrol. 2006 May; 1(3):455-61.
Score: 0.007
-
Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis. 2006 Feb; 47(2):301-8.
Score: 0.007
-
Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
Score: 0.007
-
Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients. Kidney Int. 2005 Dec; 68(6):2857-62.
Score: 0.007
-
Habitual caffeine intake and the risk of hypertension in women. JAMA. 2005 Nov 09; 294(18):2330-5.
Score: 0.007
-
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005 Aug; 46(2):225-32.
Score: 0.007
-
Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int. 2005 May; 67(5):1980-5.
Score: 0.007
-
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study. Ann Rheum Dis. 2025 Feb; 84(2):201-209.
Score: 0.007
-
Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism. Circulation. 2004 Dec 14; 110(24 Suppl 1):IV25-32.
Score: 0.007
-
Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant. 2004 Dec; 4(12):2075-81.
Score: 0.007
-
Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005 Jan; 16(1):255-60.
Score: 0.007
-
Trends in Kidney Allograft Failure Among First-Time Transplant Recipients in the United States. Am J Kidney Dis. 2025 Mar; 85(3):273-283.e1.
Score: 0.007
-
Effects of dialysate potassium concentration of 3.0?mmol/l with sodium zirconium cyclosilicate on?dialysis-free days versus dialysate potassium?concentration of 2.0 mmol/l alone on?rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney Int. 2025 Jan; 107(1):169-179.
Score: 0.007
-
Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities. Am J Kidney Dis. 2025 Feb; 85(2):226-235.e1.
Score: 0.006
-
Patterns of co-occurrence of three single nucleotide polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene in kidney transplant recipients. Eur J Clin Invest. 2004 Sep; 34(9):613-8.
Score: 0.006
-
C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant. 2004 Jul; 4(7):1148-54.
Score: 0.006
-
Knowledge and attitude regarding organ donation among medical students and physicians. Transplantation. 2004 Jun 15; 77(11):1714-8.
Score: 0.006
-
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2024 Sep; 106(3):369-391.
Score: 0.006
-
Effects of TCN2 776C>G on vitamin B, folate, and total homocysteine levels in kidney transplant patients. Kidney Int. 2004 May; 65(5):1877-81.
Score: 0.006
-
Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004 May; 15(5):1347-52.
Score: 0.006
-
Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis. 2004 May; 174(1):43-8.
Score: 0.006
-
Propensity scores: help or hype? Nephrol Dial Transplant. 2004 Jul; 19(7):1671-3.
Score: 0.006
-
Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol. 2004 Apr; 15(4):1052-60.
Score: 0.006
-
Prescription and Dispensation of QT-Prolonging Medications in Individuals Receiving Hemodialysis. JAMA Netw Open. 2024 04 01; 7(4):e248732.
Score: 0.006
-
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nat Med. 2024 Feb; 30(2):435-442.
Score: 0.006
-
Hetastarch and bleeding complications after coronary artery surgery. Chest. 2003 Oct; 124(4):1437-42.
Score: 0.006
-
Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis. Nephrol Dial Transplant. 2023 09 29; 38(10):2358-2367.
Score: 0.006
-
Market Competition and Anemia Management in the United States Following Dialysis Payment Reform. Med Care. 2023 Nov 01; 61(11):787-795.
Score: 0.006
-
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
Score: 0.006
-
Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 09; 104(3):441-454.
Score: 0.006
-
Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int. 2003 Jun; 63(6):2280-5.
Score: 0.006
-
Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 11; 104(5):888-903.
Score: 0.006
-
Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 12; 104(6):1076-1091.
Score: 0.006
-
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 10; 104(4):655-680.
Score: 0.006
-
The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003 May; 63(5):1836-42.
Score: 0.006
-
Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group. Kidney Int. 2023 06; 103(6):1028-1037.
Score: 0.006
-
Iron Sucrose and Blood Pressure Patterns During Hemodialysis. Am J Kidney Dis. 2023 06; 81(6):629-631.
Score: 0.006
-
US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2023 03; 81(3 Suppl1):A8-A11.
Score: 0.006
-
Physiological Age by Artificial Intelligence-Enhanced Electrocardiograms as a Novel Risk Factor of Mortality in Kidney Transplant Candidates. Transplantation. 2023 06 01; 107(6):1365-1372.
Score: 0.006
-
A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003 Feb; 14(2):486-92.
Score: 0.006
-
Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 05; 103(5):842-858.
Score: 0.006
-
Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery. Am J Kidney Dis. 2003 Jan; 41(1):84-9.
Score: 0.006
-
Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials. Am J Nephrol. 2022; 53(10):701-710.
Score: 0.006
-
Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. JAMA. 2022 11 08; 328(18):1837-1848.
Score: 0.006
-
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. Circulation. 2022 12 06; 146(23):1735-1745.
Score: 0.006
-
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study. Nephrol Dial Transplant. 2022 10 19; 37(11):2241-2252.
Score: 0.006
-
Association of Bradycardia and Asystole Episodes with Dialytic Parameters: An Analysis of the Monitoring in Dialysis (MiD) Study. Kidney360. 2022 11 24; 3(11):1871-1880.
Score: 0.006
-
Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Cardiovasc Res. 2022 09 20; 118(12):2582-2595.
Score: 0.006
-
Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep; 13(9):2353-62.
Score: 0.006
-
Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
Score: 0.006
-
A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
Score: 0.006
-
Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med. 2002 Aug; 17(8):588-95.
Score: 0.006
-
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. Am J Hematol. 2022 09; 97(9):1178-1188.
Score: 0.006
-
Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23.
Score: 0.006
-
Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure. Kidney Int. 2022 10; 102(4):894-903.
Score: 0.006
-
Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group study. Pediatr Nephrol. 2023 01; 38(1):249-260.
Score: 0.005
-
US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2022 04; 79(4 Suppl 1):A8-A12.
Score: 0.005
-
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 06; 31(6):670-679.
Score: 0.005
-
Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 06; 33(6):1063-1072.
Score: 0.005
-
Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease. Diabetes Obes Metab. 2022 05; 24(5):928-937.
Score: 0.005
-
Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate. JAMA Netw Open. 2022 02 01; 5(2):e220460.
Score: 0.005
-
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. 2022 01 01; 7(1):75-83.
Score: 0.005
-
Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001 Dec; 38(6):1178-84.
Score: 0.005
-
Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials. Nephrol Dial Transplant. 2021 11 09; 36(11):2039-2048.
Score: 0.005
-
Ultrafiltration rate and incident atrial fibrillation among older individuals initiating hemodialysis. Nephrol Dial Transplant. 2021 11 09; 36(11):2084-2093.
Score: 0.005
-
Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54.
Score: 0.005
-
Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
Score: 0.005
-
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney Int. 2021 12; 100(6):1199-1207.
Score: 0.005
-
Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2021 09 27; 36(10):1893-1899.
Score: 0.005
-
Long-Term Exposures to Air Pollution and the Risk of Atrial Fibrillation in the Women's Health Initiative Cohort. Environ Health Perspect. 2021 09; 129(9):97007.
Score: 0.005
-
Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population-based prospective cohort study. J Thromb Haemost. 2021 12; 19(12):2984-2996.
Score: 0.005
-
Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
Score: 0.005
-
Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021 09; 100(3):516-526.
Score: 0.005
-
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2021 07; 100(1):35-48.
Score: 0.005
-
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. N Engl J Med. 2021 04 29; 384(17):1589-1600.
Score: 0.005
-
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis. N Engl J Med. 2021 04 29; 384(17):1601-1612.
Score: 0.005
-
Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1.
Score: 0.005
-
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 2021 06; 99(6):1280-1295.
Score: 0.005
-
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2021 04; 77(4 Suppl 1):A7-A8.
Score: 0.005
-
Optic neuropathy in uremia: an interdisciplinary emergency. Am J Kidney Dis. 2001 Mar; 37(3):E23.
Score: 0.005
-
The impact of COVID-19 on kidney transplantation and the kidney transplant recipient - One year into the pandemic. Transpl Int. 2021 04; 34(4):612-621.
Score: 0.005
-
Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 03 03; 77(3):948-959.
Score: 0.005
-
Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 01 01; 36(1):129-136.
Score: 0.005
-
Nomenclature for kidney function and disease-executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Eur Heart J. 2020 12 21; 41(48):4592-4598.
Score: 0.005
-
Intradialytic Hypotension and Newly Recognized Peripheral Artery Disease in Patients Receiving Hemodialysis. Am J Kidney Dis. 2021 05; 77(5):730-738.
Score: 0.005
-
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Pediatr Nephrol. 2020 12; 35(12):2191-2200.
Score: 0.005
-
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation. Kidney Int. 2020 12; 98(6):1407-1418.
Score: 0.005
-
Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease. Expert Opin Investig Drugs. 2000 Nov; 9(11):2637-51.
Score: 0.005
-
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Ren Fail. 2020 Nov; 42(1):560-566.
Score: 0.005
-
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and?managing kidney cancer. Kidney Int. 2020 11; 98(5):1108-1119.
Score: 0.005
-
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics. Am Heart J. 2021 05; 235:1-11.
Score: 0.005
-
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2021 01; 99(1):34-47.
Score: 0.005
-
Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020 10 01; 35(10):1761-1769.
Score: 0.005
-
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes Consensus Conference. Transplantation. 2020 10; 104(10):1986-1994.
Score: 0.005
-
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Transpl Int. 2020 09; 33(9):999-1009.
Score: 0.005
-
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Clin Exp Nephrol. 2020 09; 24(9):737-747.
Score: 0.005
-
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. J Nephrol. 2020 08; 33(4):639-648.
Score: 0.005
-
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Nephrology (Carlton). 2020 08; 25(8):589-598.
Score: 0.005
-
Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks-A Narrative Review. Mayo Clin Proc. 2020 10; 95(10):2204-2224.
Score: 0.005
-
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. J Ren Nutr. 2020 07; 30(4):e41-e50.
Score: 0.005
-
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Semin Nephrol. 2020 07; 40(4):329-337.
Score: 0.005
-
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Perit Dial Int. 2021 01; 41(1):5-14.
Score: 0.005
-
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Am J Transplant. 2021 02; 21(2):901-902.
Score: 0.005
-
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Am J Nephrol. 2020; 51(7):579-588.
Score: 0.005
-
Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. J Am Heart Assoc. 2020 07 07; 9(13):e015969.
Score: 0.005
-
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Am J Kidney Dis. 2020 08; 76(2):157-160.
Score: 0.005
-
Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study. Am J Kidney Dis. 2020 11; 76(5):679-689.
Score: 0.005
-
Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach. Ann Intern Med. 2020 09 15; 173(6):489-491.
Score: 0.005
-
Re-estimation improved the performance of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis. Sci Rep. 2020 05 18; 10(1):8140.
Score: 0.005
-
Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop. Am J Kidney Dis. 2020 07; 76(1):109-120.
Score: 0.005
-
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 2020 08; 98(2):294-309.
Score: 0.005
-
[Hospitalization and Critical Illness in Chronic Kidney Disease]. Cardiorenal Med. 2020; 10(5):302-312.
Score: 0.005
-
Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study. Sci Rep. 2020 04 06; 10(1):5964.
Score: 0.005
-
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020 06; 97(6):1117-1129.
Score: 0.005
-
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 05; 97(5):861-876.
Score: 0.005
-
Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
Score: 0.005
-
Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
Score: 0.005
-
Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181.
Score: 0.005
-
Safety-Net Care for Maintenance Dialysis in the United States. J Am Soc Nephrol. 2020 02; 31(2):424-433.
Score: 0.005
-
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 01; 97(1):42-61.
Score: 0.005
-
Chronic Kidney Disease and Coronary?Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 10 08; 74(14):1823-1838.
Score: 0.005
-
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 10; 96(4):836-849.
Score: 0.005
-
Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. J Diabetes Complications. 2019 11; 33(11):107423.
Score: 0.005
-
A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes. PLoS One. 2019; 14(7):e0218709.
Score: 0.005
-
Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658.
Score: 0.004
-
Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. JAMA Netw Open. 2019 05 03; 2(5):e193987.
Score: 0.004
-
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 05; 95(5):1027-1036.
Score: 0.004
-
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 06; 95(6):1304-1317.
Score: 0.004
-
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration. J Am Soc Nephrol. 2019 05; 30(5):890-903.
Score: 0.004
-
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 07; 96(1):37-47.
Score: 0.004
-
Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. J Med Econ. 2019 Jun; 22(6):593-604.
Score: 0.004
-
Identifying Important Outcomes for Young People With CKD and Their Caregivers: A Nominal Group Technique Study. Am J Kidney Dis. 2019 07; 74(1):82-94.
Score: 0.004
-
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 02; 95(2):268-280.
Score: 0.004
-
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 02; 95(2):281-295.
Score: 0.004
-
Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. J Am Soc Nephrol. 2019 02; 30(2):346-353.
Score: 0.004
-
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
Score: 0.004
-
Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
Score: 0.004
-
External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis. Int J Cardiol. 2019 05 15; 283:165-170.
Score: 0.004
-
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney Int. 2018 12; 94(6):1053-1068.
Score: 0.004
-
Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Intern Med. 2018 10 01; 178(10):1358-1367.
Score: 0.004
-
The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1517-1525.
Score: 0.004
-
Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
Score: 0.004
-
Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45.
Score: 0.004
-
Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
Score: 0.004
-
Child and Parental Perspectives on Communication and Decision Making in Pediatric CKD: A Focus Group Study. Am J Kidney Dis. 2018 10; 72(4):547-559.
Score: 0.004
-
Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant. 2018 07 01; 33(7):1207-1214.
Score: 0.004
-
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J. 2018 06 21; 39(24):2314-2325.
Score: 0.004
-
Cardiovascular Outcomes Reported in Hemodialysis Trials. J Am Coll Cardiol. 2018 06 19; 71(24):2802-2810.
Score: 0.004
-
Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis. 2018 10; 72(4):620-622.
Score: 0.004
-
Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study. BMJ Open. 2018 04 20; 8(4):e021198.
Score: 0.004
-
Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a?Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018 06; 93(6):1281-1292.
Score: 0.004
-
High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
Score: 0.004
-
Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review. Am J Kidney Dis. 2018 07; 72(1):62-74.
Score: 0.004
-
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving?Global Outcomes (KDIGO) Controversies?Conference. Kidney Int. 2018 03; 93(3):545-559.
Score: 0.004
-
Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
Score: 0.004
-
Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 10; 92(4):796-808.
Score: 0.004
-
Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid. Arthritis Care Res (Hoboken). 2017 11; 69(11):1620-1626.
Score: 0.004
-
Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1778-1786.
Score: 0.004
-
Hospitalizations and Nursing Facility Stays During the Transition from CKD to ESRD on Dialysis: An Observational Study. J Gen Intern Med. 2017 Nov; 32(11):1220-1227.
Score: 0.004
-
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 08; 92(2):297-305.
Score: 0.004
-
Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281.
Score: 0.004
-
A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis. Stat Med. 2017 Jul 30; 36(17):2750-2763.
Score: 0.004
-
Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients. Transplantation. 2017 Apr; 101(4):851-857.
Score: 0.004
-
Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. Am J Kidney Dis. 2017 Oct; 70(4):464-475.
Score: 0.004
-
Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
Score: 0.004
-
Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications. Arthritis Rheumatol. 2017 02; 69(2):387-397.
Score: 0.004
-
Warfarin Initiation, Atrial Fibrillation, and Kidney Function:?Comparative Effectiveness and Safety of?Warfarin?in?Older?Adults?With Newly Diagnosed Atrial?Fibrillation. Am J Kidney Dis. 2017 Jun; 69(6):734-743.
Score: 0.004
-
Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. J Cardiovasc Electrophysiol. 2017 01; 28(1):39-48.
Score: 0.004
-
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017 Feb; 69(2):266-277.
Score: 0.004
-
Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease. Heart. 2017 06; 103(11):818-826.
Score: 0.004
-
Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. Am J Kidney Dis. 2017 Feb; 69(2):237-246.
Score: 0.004
-
Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):536-545.
Score: 0.004
-
Phosphate Binders: The Evidence Gap Persists. Am J Kidney Dis. 2016 11; 68(5):667-670.
Score: 0.004
-
The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients. Clin Lab. 2016 Oct 01; 62(10):1965-1972.
Score: 0.004
-
Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Trials. 2016 08 12; 17:401.
Score: 0.004
-
Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop. Am J Kidney Dis. 2017 Jan; 69(1):97-107.
Score: 0.004
-
Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis. Clin J Am Soc Nephrol. 2016 08 08; 11(8):1401-1412.
Score: 0.004
-
Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
Score: 0.004
-
Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21.
Score: 0.004
-
Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study. Am J Kidney Dis. 2016 Sep; 68(3):444-54.
Score: 0.004
-
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. Am J Transplant. 2016 05; 16(5):1492-502.
Score: 0.004
-
Federal Funding for Kidney Disease Research: A Missed Opportunity. Am J Public Health. 2016 Mar; 106(3):406-7.
Score: 0.004
-
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. J Am Soc Nephrol. 2016 Oct; 27(10):3129-3138.
Score: 0.004
-
A Cost Analysis of Tolerance Induction for Two-Haplotype Match Kidney Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):371-3.
Score: 0.003
-
Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related?Quality of Life in Patients Receiving?Hemodialysis. Am J Kidney Dis. 2016 Feb; 67(2):271-82.
Score: 0.003
-
Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2016 Jan; 25(1):90-9.
Score: 0.003
-
Perspectives on Pregnancy in Women With CKD: A Semistructured Interview Study. Am J Kidney Dis. 2015 Dec; 66(6):951-61.
Score: 0.003
-
Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis. Arthritis Care Res (Hoboken). 2015 Oct; 67(10):1453-62.
Score: 0.003
-
Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients. Am J Kidney Dis. 2016 Jan; 67(1):119-27.
Score: 0.003
-
Menopausal symptoms in women with chronic kidney disease. Menopause. 2015 Sep; 22(9):1006-11.
Score: 0.003
-
Kidney Function and Cardiovascular Events in Postmenopausal Women: The Impact of Race and Ethnicity in the Women's Health Initiative. Am J Kidney Dis. 2016 Feb; 67(2):198-208.
Score: 0.003
-
Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis. Trials. 2015 Aug 19; 16:364.
Score: 0.003
-
Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. PLoS One. 2015; 10(8):e0135674.
Score: 0.003
-
Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015 Jun; 67(6):1577-85.
Score: 0.003
-
Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study. Appl Health Econ Health Policy. 2015 Apr; 13(2):193-205.
Score: 0.003
-
Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records. Biometrics. 2015 Jun; 71(2):478-86.
Score: 0.003
-
The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study. BMJ. 2015 Feb 03; 350:h246.
Score: 0.003
-
Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
Score: 0.003
-
Research priority setting in kidney disease: a systematic review. Am J Kidney Dis. 2015 May; 65(5):674-83.
Score: 0.003
-
Adiposity patterns and the risk for ESRD in postmenopausal women. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):241-50.
Score: 0.003
-
Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7.
Score: 0.003
-
Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol. 2014 Aug 19; 64(7):660-8.
Score: 0.003
-
Patients' perspectives on hemodialysis vascular access: a systematic review of qualitative studies. Am J Kidney Dis. 2014 Dec; 64(6):937-53.
Score: 0.003
-
Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
Score: 0.003
-
Earlier- versus later-start peritoneal dialysis: not a moment too soon? Am J Kidney Dis. 2014 May; 63(5):741-4.
Score: 0.003
-
Qualitative research in CKD: an overview of methods and applications. Am J Kidney Dis. 2014 Sep; 64(3):338-46.
Score: 0.003
-
Comparison of Medicare claims versus physician adjudication for identifying stroke outcomes in the Women's Health Initiative. Stroke. 2014 Mar; 45(3):815-21.
Score: 0.003
-
Addressing missing data in clinical studies of kidney diseases. Clin J Am Soc Nephrol. 2014 Jul; 9(7):1328-35.
Score: 0.003
-
Prognostic stratification in older adults commencing dialysis. J Gerontol A Biol Sci Med Sci. 2014 Aug; 69(8):1033-9.
Score: 0.003
-
Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):157-62.
Score: 0.003
-
Coronary artery bypass graft type and outcomes in maintenance dialysis. J Cardiovasc Surg (Torino). 2015 Jun; 56(3):463-71.
Score: 0.003
-
Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One. 2013; 8(11):e78930.
Score: 0.003
-
Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records. Clin J Am Soc Nephrol. 2014 Jan; 9(1):82-91.
Score: 0.003
-
Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2149-57.
Score: 0.003
-
Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2213-20.
Score: 0.003
-
Multivessel coronary revascularization and outcomes in kidney transplant recipients. Transpl Int. 2013 Nov; 26(11):1080-7.
Score: 0.003
-
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013 Jun; 24(7):1151-8.
Score: 0.003
-
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. Transplantation. 2013 Jun 15; 95(11):1338-45.
Score: 0.003
-
Fostering innovation, advancing patient safety: the kidney health initiative. Clin J Am Soc Nephrol. 2013 Sep; 8(9):1609-17.
Score: 0.003
-
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med. 2013 Jun; 126(6):541.e1-541.e14.
Score: 0.003
-
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 2013 Mar; 65(3):753-63.
Score: 0.003
-
Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
Score: 0.003
-
Epidemiologic and statistical methods for comparative effectiveness research. Heart Fail Clin. 2013 Jan; 9(1):29-36.
Score: 0.003
-
Preoperative statin use and postoperative acute kidney injury. Am J Med. 2012 Dec; 125(12):1195-1204.e3.
Score: 0.003
-
Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients. Clin Nephrol. 2012 Sep; 78(3):181-8.
Score: 0.003
-
Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012 Aug; 64(8):2669-76.
Score: 0.003
-
The prevalence and cost of unapproved uses of top-selling orphan drugs. PLoS One. 2012; 7(2):e31894.
Score: 0.003
-
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.
Score: 0.003
-
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum. 2011 Jul; 63(7):1988-97.
Score: 0.003
-
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011 Jun; 63(6):1681-8.
Score: 0.003
-
Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. Nephrol Dial Transplant. 2012 Jan; 27(1):429-34.
Score: 0.003
-
Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure. J Card Fail. 2011 Jul; 17(7):533-9.
Score: 0.003
-
Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors: challenges in comparative effectiveness using Medicare data. Clin Pharmacol Ther. 2011 May; 89(5):674-82.
Score: 0.003
-
World Kidney Day 2011. J Am Soc Nephrol. 2011 Mar; 22(3):397-8.
Score: 0.003
-
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease. BMC Nephrol. 2011 Feb 16; 12:9.
Score: 0.003
-
Late referral to paediatric renal failure service impairs access to pre-emptive kidney transplantation in children. Arch Dis Child. 2010 Aug; 95(8):634-8.
Score: 0.002
-
HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival. BMC Nephrol. 2010 Apr 01; 11:5.
Score: 0.002
-
Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials. Transplantation. 2009 Dec 27; 88(12):1377-85.
Score: 0.002
-
Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Pharmacoepidemiol Drug Saf. 2009 Oct; 18(10):932-40.
Score: 0.002
-
Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations. Am J Kidney Dis. 2009 Sep; 54(3):554-60.
Score: 0.002
-
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008 Dec; 17(12):1189-96.
Score: 0.002
-
Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis. 2008 May; 51(5):811-8.
Score: 0.002
-
No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients. Am J Nephrol. 2007; 27(4):390-6.
Score: 0.002
-
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients. Arch Intern Med. 2007 Apr 23; 167(8):840-6.
Score: 0.002
-
Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol. 2007 Aug; 22(8):1189-93.
Score: 0.002
-
Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int. 2007 Mar; 20(3):247-55.
Score: 0.002
-
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis. Pharmacoeconomics. 2007; 25(11):949-61.
Score: 0.002
-
The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survival. Transplantation. 2006 Dec 15; 82(11):1441-8.
Score: 0.002
-
Renal dysfunction increases the risk of saphenous vein graft occlusion: results from the Post-CABG trial. Atherosclerosis. 2007 Aug; 193(2):414-20.
Score: 0.002
-
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int. 2006 Aug; 19(8):629-35.
Score: 0.002
-
Surrogate markers in clinical studies: problems solved or created? Am J Kidney Dis. 2006 Jul; 48(1):159-66.
Score: 0.002
-
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol. 2006 Jun; 17(6):1688-94.
Score: 0.002
-
Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thorac Surg. 2006 Apr; 81(4):1385-92.
Score: 0.002
-
Prognostic associations between lipid markers and outcomes in kidney transplant recipients. Am J Kidney Dis. 2006 Mar; 47(3):509-17.
Score: 0.002
-
Endothelial progenitor cells in kidney transplant recipients. Transplantation. 2006 Feb 27; 81(4):599-606.
Score: 0.002
-
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006 Mar; 17(3):889-99.
Score: 0.002
-
Genetic aspects of hyperhomocysteinemia in chronic kidney disease. Semin Nephrol. 2006 Jan; 26(1):8-13.
Score: 0.002
-
Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure. Circulation. 2005 Dec 13; 112(24):3745-53.
Score: 0.002
-
Anaemia after renal transplantation. Eur J Clin Invest. 2005 Dec; 35 Suppl 3:89-94.
Score: 0.002
-
Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation. 2005 Sep 15; 80(5):582-9.
Score: 0.002
-
The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis. 2005 Aug 01; 41(3):301-7.
Score: 0.002
-
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Haemophilia. 2005 May; 11(3):261-9.
Score: 0.002
-
Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis. Kidney Int. 2004 Oct; 66(4):1712; author reply 1712-3.
Score: 0.002
-
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int. 2004 Sep; 66(3):1239-47.
Score: 0.002
-
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clin Transplant. 2004 Aug; 18(4):341-8.
Score: 0.002
-
How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004 Jan; 13(1):11-9.
Score: 0.002
-
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney Int. 2003 Jul; 64(1):295-304.
Score: 0.001
-
Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
Score: 0.001
-
Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
Score: 0.001
-
Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000 Jun; 11(6):1106-1116.
Score: 0.001